Firebrick Pharma LimitedASX: FRE

Corporate Governance Statement

Aug 31, 2026 at 3:23 AM EDT · Issued by Firebrick Pharma Limited via ASX

Filed with ASX · Aug 31, 2026 at 3:23 AM EDT

On 6ix: 6ix.com/news/corporate-governance-statement-69

Firebrick Pharma Limited ABN 64 157 765 896 L14, 333 Collins St Melbourne VIC 3000 Australia Corporate Governance Statement The Board of Directors of Firebrick Pharma Limited ( Firebrick or the Company ) ABN 64 157 765 896 is responsible for: • the...

View Attachment

6ix hasn’t read this filing yet.

Firebrick Pharma Limited on 6ix

Earlier from Firebrick Pharma

Cleansing NoticeAug 10
Application for quotation of securities - FREAug 10
Proposed issue of securities - FREAug 9
Investor UpdateJul 26
March 2026 Quarterly Activity Report & Appendix 4CApr 21

Later from Firebrick Pharma

Appendix 4GAug 31
Appendix 4E and Annual Report 30 June 2026Aug 31
Notice of AGM and Closing Date for Director NominationsSep 14
Firebrick receives $293,000 R&D Tax IncentiveSep 22
Firebrick announces USA Retail Launch PlanSep 28

All Firebrick Pharma news releases

Follow Firebrick Pharma into a list and get an email when it puts out news.

Follow Firebrick Pharma